Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 5/20 | 0.59 |
| ▸ | C1R | P00736 | 6/20 | 0.56 |
| ▸ | F2 | P00734 | 3/20 | 0.56 |
| ▸ | PLG | P00747 | 1/20 | 0.56 |
| ▸ | KLK1 | P06870 | 1/20 | 0.56 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.56 |
| ▸ | C1S | P09871 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.52 |
| ▸ | NPC1 | O15118 | 3/20 | 0.52 |
| ▸ | RAB9A | P51151 | 3/20 | 0.52 |
| ▸ | HPGD | P15428 | 3/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.52 |
| ▸ | ATM | Q13315 | 1/20 | 0.52 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL272287 | 0.80 | ELANE (0.81) | ELANEC1RF2PLGKLK1 | |
| SCHEMBL12352106 | 0.79 | ELANE (0.69) | ELANEC1RF2PLGKLK1 | |
| SCHEMBL12352121 | 0.78 | ELANE (0.67) | ELANEC1RF2PLGKLK1 | |
| SCHEMBL13700941 | 0.77 | ELANE (0.71) | ELANEC1RF2PLGKLK1 | |
| SCHEMBL12352120 | 0.76 | ELANE (0.65) | ELANEC1RF2PLGKLK1 | |
| SCHEMBL13700912 | 0.76 | ELANE (0.59) | ELANEC1RF2PLGKLK1 | |
| SCHEMBL9475884 | 0.75 | C1R (0.78) | ELANEC1RF2PLGKLK1 | |
| SCHEMBL2537274 | 0.75 | ELANE (0.73) | ELANEC1RF2PLGKLK1 | |
| SCHEMBL30914649 | 0.75 | ELANE (0.73) | ELANEC1RF2PLGKLK1 | |
| SCHEMBL29456973 | 0.75 | ELANE (0.93) | ELANEC1RF2PLGKLK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8541488-B2 | Formed resin article and polymer film | FUJIFILM CORPORATION (JP) | 2013-09-24 | — | — | US | disclosed |
| US-8541488-B2 | Formed resin article and polymer film | FUJIFILM CORPORATION (JP) | 2013-09-24 | — | — | US | disclosed |
| US-20110186791-A1 | ULTRAVIOLET ABSORBENT COMPOSITION | FUJIFILM CORPORATION (JP) | 2011-08-04 | — | — | US | disclosed |
| US-20110186791-A1 | ULTRAVIOLET ABSORBENT COMPOSITION | FUJIFILM CORPORATION (JP) | 2011-08-04 | — | — | US | disclosed |
| US-20110163284-A1 | LIGHTING UNIT COVER | FUJIFILM CORPORATION (JP) | 2011-07-07 | — | — | US | disclosed |
| US-20110163284-A1 | LIGHTING UNIT COVER | FUJIFILM CORPORATION (JP) | 2011-07-07 | — | — | US | disclosed |
| US-20110092619-A1 | FORMED RESIN ARTICLE AND POLYMER FILM | FUJIFILM CORPORATION (JP) | 2011-04-21 | — | — | US | disclosed |
| US-20110092619-A1 | FORMED RESIN ARTICLE AND POLYMER FILM | FUJIFILM CORPORATION (JP) | 2011-04-21 | — | — | US | disclosed |
| US-7897761-B2 | Heterocyclic compound | FUJIFILM CORPORATION (JP) | 2011-03-01 | — | — | US | disclosed |
| US-7897761-B2 | Heterocyclic compound | FUJIFILM CORPORATION (JP) | 2011-03-01 | — | — | US | disclosed |
| US-20110024701-A1 | Ultraviolet Absorbent Composition | FUJIFILM CORPORATION (JP) | 2011-02-03 | — | — | US | disclosed |
| US-20110024701-A1 | Ultraviolet Absorbent Composition | FUJIFILM CORPORATION (JP) | 2011-02-03 | — | — | US | disclosed |
| US-20100004439-A1 | Heterocyclic Compound | FUJIFLM CORPORATION (JP) | 2010-01-07 | — | — | US | disclosed |
| US-20100004439-A1 | Heterocyclic Compound | FUJIFLM CORPORATION (JP) | 2010-01-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100004439-A1 | Heterocyclic Compound | PTGER1, CYP1A1, ALOX12 | ELANE 1343/4885C1R 959/4885F2 56/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.